Drug Channels Report: U.S. Drug Channel Consolidation Continues Amidst Debate Over Anti-Competitive Practices.

Drug Channels has released its annual update examining vertical integration trends within the U.S. drug channels. The report focuses on the relationships between major insurers, pharmacy benefit managers (PBMs), specialty pharmacies, and healthcare service providers. The analysis highlights the ongoing consolidation and selective deconsolidation activities that continue to reshape the healthcare landscape. The updated illustration depicts the complex web of business relationships among the largest companies in these sectors. Drug Channels notes that proponents argue vertical integration can reduce healthcare costs. However, these arrangements remain a source of debate due to concerns about potential anti-competitive practices. The report also acknowledges that while some companies have streamlined their operations or reversed previous integration efforts, the broader trend of consolidation and strategic deconsolidation persists in the healthcare industry.

Newsflash | Powered by GeneOnline AI
Date: April 9, 2025

Author

Mark Chiang